Cellceutix begins Phase IIb clinical trial of Prurisol to treat psoriasis

US-based clinical stage biopharmaceutical company Cellceutix has begun its Phase IIb clinical trial of Prurisol to treat moderate-to-severe chronic plaque psoriasis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news